Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 11158
TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595657(US11591328, Compound 10)
Affinity DataIC50: 0.550nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595552(US11591328, Compound 1)
Affinity DataIC50: 0.660nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595580(US11591328, Compound 3)
Affinity DataIC50: 1.10nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595662(US11591328, Compound 15)
Affinity DataIC50: 1.20nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595673(US11591328, Compound 26)
Affinity DataIC50: 1.40nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595672(US11591328, Compound 25)
Affinity DataIC50: 2nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595656(US11591328, Compound 9)
Affinity DataIC50: 2.10nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595655(US11591328, Compound 8)
Affinity DataIC50: 2.30nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595580(US11591328, Compound 3)
Affinity DataIC50: 2.60nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595654(US11591328, Compound 7)
Affinity DataIC50: 2.70nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595668(US11591328, Compound 21)
Affinity DataIC50: 2.80nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595552(US11591328, Compound 1)
Affinity DataIC50: 3.5nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595673(US11591328, Compound 26)
Affinity DataIC50: 4.5nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595665(US11591328, Compound 18)
Affinity DataIC50: 4.70nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595671(US11591328, Compound 24)
Affinity DataIC50: 4.80nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595672(US11591328, Compound 25)
Affinity DataIC50: 5nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595670(US11591328, Compound 23)
Affinity DataIC50: 5.30nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595653(US11591328, Compound 6)
Affinity DataIC50: 5.40nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595579(US11591328, Compound 2)
Affinity DataIC50: 5.40nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595666(US11591328, Compound 19)
Affinity DataIC50: 5.40nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595667(US11591328, Compound 20)
Affinity DataIC50: 5.90nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595579(US11591328, Compound 2)
Affinity DataIC50: 6.20nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595661(US11591328, Compound 14)
Affinity DataIC50: 6.20nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595663(US11591328, Compound 16)
Affinity DataIC50: 6.40nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595664(US11591328, Compound 17)
Affinity DataIC50: 6.5nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595669(US11591328, Compound 22)
Affinity DataIC50: 6.70nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595665(US11591328, Compound 18)
Affinity DataIC50: 8.40nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595651(US11591328, Compound 4)
Affinity DataIC50: 8.5nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595652(US11591328, Compound 5)
Affinity DataIC50: 9.10nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595668(US11591328, Compound 21)
Affinity DataIC50: 10.1nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595666(US11591328, Compound 19)
Affinity DataIC50: 11nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595651(US11591328, Compound 4)
Affinity DataIC50: 16nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595661(US11591328, Compound 14)
Affinity DataIC50: 17nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595671(US11591328, Compound 24)
Affinity DataIC50: 20nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595667(US11591328, Compound 20)
Affinity DataIC50: 24.7nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595660(US11591328, Compound 13)
Affinity DataIC50: 25nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595662(US11591328, Compound 15)
Affinity DataIC50: 29nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595651(US11591328, Compound 4)
Affinity DataIC50: 40nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595673(US11591328, Compound 26)
Affinity DataIC50: 42nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595668(US11591328, Compound 21)
Affinity DataIC50: 43nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595672(US11591328, Compound 25)
Affinity DataIC50: 62nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595667(US11591328, Compound 20)
Affinity DataIC50: 64.6nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595665(US11591328, Compound 18)
Affinity DataIC50: 65nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595671(US11591328, Compound 24)
Affinity DataIC50: 93nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595552(US11591328, Compound 1)
Affinity DataIC50: 101nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595666(US11591328, Compound 19)
Affinity DataIC50: 121nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595659(US11591328, Compound 12)
Affinity DataIC50: 171nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595661(US11591328, Compound 14)
Affinity DataIC50: 198nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetMacrophage colony-stimulating factor 1 receptor(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595658(US11591328, Compound 11)
Affinity DataIC50: 300nMAssay Description:CSF1R: The specific operation is as follows: Set the concentration gradient of the test compound and dilute the test compound to the working concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Xiamen Biotime Biotechnology

US Patent
LigandPNGBDBM595665(US11591328, Compound 18)
Affinity DataIC50: 343nMAssay Description:c-Kit, PDGFRα, PDGFRβ, FLT-3:Add 5 μL of compound (10% DMSO) at 5 times the final concentration of the reaction to a 384-well plate. A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/14/2023
Entry Details
US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: